Nov 2018 $10 M No. 5 $10 to $50 million 31
Vavotar Life Sciences, LLC: Raise no. 5, Nov 2018 × Investors in this round 31 investors had bought by the notice of Jan 18, 2019: 31 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $10 M offered
Smallest investment taken $6,250
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions $156,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Limited Liability Company, incorporated in Delaware People named in the notice Charles Farrahar · Executive Officer Steve Gorlin · Executive Officer, Director Andrew Danielsen · Director James A. Rogers · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Finsoft Consultants, Inc. · New York, New York Sold in CO, CT, FL, GA, NY, OK, PA, TN, TX Ashley Johnson · Destin, Florida Sold in CO, CT, FL, GA, NY, OK, PA, TN, TX Virginia Dadey · Palm Beach, Florida Sold in CO, CT, FL, GA, NY, OK, PA, TN, TX Signed by Charles Farrahar, Cfo. Source: SEC Form D, newest notice filed Jan 18, 2019. Read the notice at the SEC .
equity SEC Aug 2016 $81 M No. 4 $50 to $250 million 1
Vavotar Life Sciences, LLC: Raise no. 4, Aug 2016 × Investors in this round 1 investor had bought by the notice of Sep 23, 2016: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $81 M of $81 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Delaware People named in the notice Charles Farrahar · Executive Officer Jesse W. Crowne · Executive Officer Martin A. Bell · Executive Officer Steve Gorlin · Executive Officer, Director Patrick W. Soon-Shiong · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Charles Farrahar, Cfo. Source: SEC Form D, newest notice filed Sep 23, 2016. Read the notice at the SEC .
equity SEC Aug 2016 $21 M No. 3 $10 to $50 million 3
Vavotar Life Sciences, LLC: Raise no. 3, Aug 2016 × Investors in this round 3 investors had bought by the notice of Sep 22, 2016: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $21 M of $21 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Delaware People named in the notice Charles Farrahar · Executive Officer Jesse W. Crowne · Executive Officer Martin A. Bell · Executive Officer Steve Gorlin · Executive Officer, Director Patrick W. Soon-Shiong · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Charles Farrahar, Cfo. Source: SEC Form D, newest notice filed Sep 22, 2016. Read the notice at the SEC .
equity SEC Aug 2016 $41 M No. 2 $10 to $50 million 1
Vavotar Life Sciences, LLC: Raise no. 2, Aug 2016 × Investors in this round 1 investor had bought by the notice of Sep 21, 2016: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $41 M of $41 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Delaware People named in the notice Charles Farrahar · Executive Officer Jesse W. Crowne · Executive Officer Martin A. Bell · Executive Officer Steve Gorlin · Executive Officer, Director Patrick W. Soon-Shiong · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Charles Farrahar, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 21, 2016. Read the notice at the SEC .
equity SEC Mar 2016 $4 M No. 1 $2 to $10 million 11
Vavotar Life Sciences, LLC: Raise no. 1, Mar 2016 × Investors in this round 11 investors had bought by the notice of May 16, 2016: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $5 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Delaware People named in the notice Charles Farrahar · Executive Officer Jesse W. Crowne · Executive Officer Martin A. Bell · Executive Officer Steve Gorlin · Executive Officer, Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Charles Farrahar, Cfo. Source: SEC Form D, newest notice filed May 16, 2016. Read the notice at the SEC .
equity SEC